Hepatic progenitor cells are bi-potential stern cells residing in human and animal livers that are able to differentiate towards the hepatocytic and the cholangiocytic lineages. In adult livers, hepatic progenitor cells are quiescent stern cells with a low proliferating rate, representing a reserve compartment that is activated only when the mature epithelial cells of the liver are continuously damaged or inhibited in their replication, or in cases of severe cell loss. Hepatic progenitor cell activation has been described in various acute and chronic liver diseases. Their niche is composed by numerous cells Such as Hepatic Stellate Cells, endothelial cells, hepatocytes, cholangiocytes, Kupffer cells. pit cells and inflammatory cells. All these cells, numerous hormones and growth factors Could interact and cross-talk with progenitor cells influencing their proliferative and differentiative processes. Hepatic progenitor cells and their niche Could represent, in the near future, a target for therapeutic approaches to liver disease based oil cell-specific drug delivery systems. Isolation and transplantation of hepatic progenitor Cells Could represent a new approach for therapy of end-stage chronic liver diseases. as they offer many advantages to transplantation of mature hepatocytes. The possibility of applying stern cell therapy to liver diseases will represent a major goal in this field. (C) 2009 Published by Elsevier Ltd oil behalf of Editrice Gastroenterologica Italiana S.r.l.
New insights into liver stem cells
G. Carpino;FRANCHITTO, Antonio;
2009-01-01
Abstract
Hepatic progenitor cells are bi-potential stern cells residing in human and animal livers that are able to differentiate towards the hepatocytic and the cholangiocytic lineages. In adult livers, hepatic progenitor cells are quiescent stern cells with a low proliferating rate, representing a reserve compartment that is activated only when the mature epithelial cells of the liver are continuously damaged or inhibited in their replication, or in cases of severe cell loss. Hepatic progenitor cell activation has been described in various acute and chronic liver diseases. Their niche is composed by numerous cells Such as Hepatic Stellate Cells, endothelial cells, hepatocytes, cholangiocytes, Kupffer cells. pit cells and inflammatory cells. All these cells, numerous hormones and growth factors Could interact and cross-talk with progenitor cells influencing their proliferative and differentiative processes. Hepatic progenitor cells and their niche Could represent, in the near future, a target for therapeutic approaches to liver disease based oil cell-specific drug delivery systems. Isolation and transplantation of hepatic progenitor Cells Could represent a new approach for therapy of end-stage chronic liver diseases. as they offer many advantages to transplantation of mature hepatocytes. The possibility of applying stern cell therapy to liver diseases will represent a major goal in this field. (C) 2009 Published by Elsevier Ltd oil behalf of Editrice Gastroenterologica Italiana S.r.l.I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.